Tandem Diabetes Care and TypeZero Technologies Announce License Agreement to Accelerate Development and Commercialization of Closed-Loop Artificial Pancreas System

Tandem Diabetes Care and TypeZero Technologies Announce License Agreement to Accelerate Development and Commercialization of Closed-Loop Artificial Pancreas System

Business Wire

View this article on Business Wire